ExeGi Pharma Announces First Patient Enrollment in the PROF Trial of EXE-346 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Probiota Americas is just over two weeks away. With key scientific and business insights into microbiome modulation to support women’s health, LBPs, and quorum sensing, don’t wait to register!
A judge in the US District Court for the Eastern District of Wisconsin has ruled in favor of ExeGi Pharma in its recent lawsuit against a competitor promoting a High Potency Probiotic as a generic equivalent of ExeGi’s Visbiome probiotic.
New Study Suggests Visbiome Vet May Support Gastrointestinal Health in Dogs Undergoing Chemotherapy Treatment
News provided by
Share this article
ROCKVILLE, Md., May 20, 2021 /PRNewswire/
A recent study published in Veterinary Record Open (Jugan, et. al) suggests that Visbiome® Vet probiotic may help mitigate occasional gastrointestinal concerns in dogs undergoing chemotherapy treatment for lymphoma.
The study was conducted at Kansas State University. Ten dogs with multicentric lymphoma were enrolled in this prospective, randomized, placebo-controlled, single-blinded study. Dogs either received an oral probiotic or an oral placebo daily.
New Study Published on Visbiome Vet in Dogs Undergoing Chemotherapy
Forty percent of dogs had an unbalanced GI microbiome at baseline, and dysbiosis was common in dogs with multicentric lymphoma.